Shilpa Biologicals is a biotech company focused on innovating and developing high-quality affordable biopharmaceuticals for patients worldwide, through cutting-edge research and creative collaborations

Shilpa Biologicals Private Limited

Deputy Manager

Senior Officer

Officer

Research Associate

Junior Research Associate

Trainee Research Associate

Piping Designer

Quality Control Executive

QC Officer

Deputy Manager EHSS

Sr.Officer -EHS

EHS  OFFICER

Research Officer-Pilot plant and Safety coordinator

Senior Manager

Manager

Research Scientist

Senior Associate Scientist

Scientist

Senior Research Associate

Research Associate-II

Quality Assurance Manager

Corporate Quality Assurance (Certified Quality Auditor )

Instrumentation and Control Engineer

Sr.Executive

Warehouse Incharge

Cloudflare DNS

Outlook

CloudFlare Hosting

WordPress.org

Google Font API

Mobile Friendly

Chief Manager

Data Integrity and Compliance

Microsoft-IIS

ASP.NET

Biocon: Enhancing Global HealthcareBiocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global biopharmaceutical enterprise serving customers in over 120 countries. Driven by a vision to enhance global healthcare through innovative and affordable biopharmaceuticals, we have enabled access to advanced therapies for diseases that are chronic, where medical needs are largely unmet and treatment costs are high. The early anticipation of the increasing dominance of biologics in global development pipelines helped us to be ahead of the curve in crafting a differentiated product portfolio based on fermentation and recombinant technologies, which straddles fermentation-derived small molecules and biologics, both novel as well as biosimilars.The significant brand equity that we have built worldwide for our small molecule APIs across statins, immunosuppresants and other specialty products has made us a leading global supplier of these products.We have also built one of the largest and most diverse biosimilar pipelines, spanning insulins, monoclonal antibodies and other recombinant proteins that address critical chronic diseases such as diabetes, cancer and autoimmune disorders.Ranked among the Top 3 biosimilar players globally for rh-insulin and insulin glargine in volume terms, we are the first Indian company to launch a biosimilar in Japan with Insulin Glargine, which also has been approved for sale in EU and Australia. Our insulin products have made a difference to the lives of millions of people with diabetes across the globe. We now aim to provide our insulin products to ‘one in five' people with diabetes in need of insulin-based therapy anywhere in the world within the next 10 years.We are also making a huge impact in the area of cancer care. Our biosimilar Trastuzumab, which was the first to be approved anywhere in the world and launched in India in 2014, has helped treat several thousand HER2-positive metastatic breast cancer patients. We are also the first company from India to get its biosimilar approved by the USFDA; Ogivri™, co-developed by Biocon and Mylan, is the first biosimilar Trastuzumab to be approved in the US. In addition to Trastuzumab, several of our biosimilar assets are on track for anticipated regulatory approvals in developed markets.We are also developing a pipeline of patented biologics to address global unmet medical needs. We have successfully launched a couple of novel biologics in India: Nimotuzumab for the treatment of head and neck cancer and Itolizumab to tackle psoriasis. Besides these, we have a basket of novel assets are under various stages of clinical development, including a high potential oral insulin.Through our subsidiary, Syngene, we offer a suite of integrated, end-to-end discovery and development services for novel molecular entities (NMEs) to the global life sciences sector.Ranked by the prestigious Science magazine among the Top 10 Best employers in the biotech industry, Biocon is passionately pursuing a mission to rationalize healthcare spends, enhance access to life-saving therapies and make a significant impact to global healthcare through ‘blockbuster' drugs with the potential to benefit a billion patients.

Biocon

Microsoft Office 365

Microsoft Azure Hosting

SuccessFactors (SAP)

Cloudways

Assistant Manager

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla's history over the years.Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla's respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.

Vaibhav Dongare

Chief Manager at Shilpa Biologicals Private Limited

Vaibhav Dongare's Professional Contact Details

Vaibhav Dongare's Current Company Details

Shilpa Biologicals Private Limited

Vaibhav Dongare's Work History and Education

Others Named Vaibhav Dongare

Frequently Asked Questions about Vaibhav Dongare

What company does Vaibhav Dongare work for?

What is Vaibhav Dongare's role at Shilpa Biologicals Private Limited?

What is Vaibhav Dongare's email address?

What is Vaibhav Dongare's business email address?

What is Vaibhav Dongare's HQ phone number?

What industry does Vaibhav Dongare work in?

Who are Vaibhav Dongare's colleagues?

Colleagues at Shilpa Biologicals Private Limited

Prospect on LinkedIn

People Search

Company Search

Erik Straub

Michael Transon

Ready to try it out?